REVENUE (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of disaggregated revenue from contracts with customers

The following table reflects summary revenue, net for the years ended December 31, 2022 and 2021 (in thousands):

	Year ended December 31,
	2022		2021
Product sales, net:
INDOCIN products	$	100,338	$	60,557
Otrexup	11,148		—
Sympazan	1,768		—
SPRIX	9,110		8,676
CAMBIA	24,720		24,972
Zipsor	3,364		10,185
Other products	4,673		5,030
Total product sales, net	155,121		109,420
Royalties and milestone revenue	2,403		2,579
Other revenue	(1,290)		(985)
Total revenues	$	156,234	$	111,014